Yu L - Search Results

1

[Effects of normal mitochondrial transplantation on proliferation, apoptosis and stemness of triple-negative breast cancer cells].

Ma LL, Zhang K, Lu JN, Sun LX, Yu L, Ran YL, Sun LC. Ma LL, et al. Among authors: yu l. Zhonghua Zhong Liu Za Zhi. 2024 Sep 23;46(9):878-888. doi: 10.3760/cma.j.cn112152-20231222-00381. Zhonghua Zhong Liu Za Zhi. 2024. PMID: 39293991 Chinese.

2

Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer.

Wang X, Song Y, Yu L, Xue X, Pang M, Li Y, Luo X, Hua Z, Lu C, Lu A, Liu Y. Wang X, et al. Among authors: yu l. ACS Appl Mater Interfaces. 2023 Jul 26;15(29):34360-34377. doi: 10.1021/acsami.3c03233. Epub 2023 Jul 11. ACS Appl Mater Interfaces. 2023. PMID: 37432741

3

Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.

Zhang Z, Luo X, Xue X, Pang M, Wang X, Yu L, Qian J, Li X, Tian M, Lu A, Lu C, Liu Y. Zhang Z, et al. Among authors: yu l. Int J Nanomedicine. 2024 Jan 23;19:743-758. doi: 10.2147/IJN.S440619. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38283199 Free PMC article.

4

Hierarchical drug release designed Au @PDA-PEG-MTX NPs for targeted delivery to breast cancer with combined photothermal-chemotherapy.

Li W, Cao Z, Yu L, Huang Q, Zhu D, Lu C, Lu A, Liu Y. Li W, et al. Among authors: yu l. J Nanobiotechnology. 2021 May 17;19(1):143. doi: 10.1186/s12951-021-00883-8. J Nanobiotechnology. 2021. PMID: 34001161 Free PMC article.

5

A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells.

Pang M, Yu L, Li X, Lu C, Xiao C, Liu Y. Pang M, et al. Among authors: yu l. Cell Death Dis. 2024 Aug 4;15(8):562. doi: 10.1038/s41419-024-06956-4. Cell Death Dis. 2024. PMID: 39098929 Free PMC article. Review.

6

The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies.

Zhang Z, Huang Q, Yu L, Zhu D, Li Y, Xue Z, Hua Z, Luo X, Song Z, Lu C, Zhao T, Liu Y. Zhang Z, et al. Among authors: yu l. Front Immunol. 2022 Jan 18;12:807895. doi: 10.3389/fimmu.2021.807895. eCollection 2021. Front Immunol. 2022. PMID: 35116035 Free PMC article. Review.

7

An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.

Xue X, Wang X, Pang M, Yu L, Qian J, Li X, Tian M, Lu C, Xiao C, Liu Y. Xue X, et al. Among authors: yu l. J Nanobiotechnology. 2024 Apr 21;22(1):196. doi: 10.1186/s12951-024-02452-1. J Nanobiotechnology. 2024. PMID: 38644492 Free PMC article. Review.

8

Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets.

Wang X, Xue X, Pang M, Yu L, Qian J, Li X, Tian M, Lyu A, Lu C, Liu Y. Wang X, et al. Among authors: yu l. MedComm (2020). 2024 Aug 1;5(8):e659. doi: 10.1002/mco2.659. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39092293 Free PMC article. Review.

9

[Effect of herbal prostatitis decoction on experimental prostatitis in rats].

Zhang YQ, Liu YF, Yu LH. Zhang YQ, et al. Among authors: yu lh. Zhong Xi Yi Jie He Za Zhi. 1991 Aug;11(8):480-1, 453-4. Zhong Xi Yi Jie He Za Zhi. 1991. PMID: 1954666 Chinese.

10

Hyaluronic Acid Hydrogels Hybridized With Au-Triptolide Nanoparticles for Intraarticular Targeted Multi-Therapy of Rheumatoid Arthritis.

Li C, Liu R, Song Y, Chen Y, Zhu D, Yu L, Huang Q, Zhang Z, Xue Z, Hua Z, Lu C, Lu A, Liu Y. Li C, et al. Among authors: yu l. Front Pharmacol. 2022 May 27;13:849101. doi: 10.3389/fphar.2022.849101. eCollection 2022. Front Pharmacol. 2022. PMID: 35712709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,942 results

Search Page

Filters